» Articles » PMID: 33441027

Platelet Proteomes, Pathways, and Phenotypes As Informants of Vascular Wellness and Disease

Overview
Date 2021 Jan 14
PMID 33441027
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets rapidly undergo responsive transitions in form and function to repair vascular endothelium and mediate hemostasis. In contrast, heterogeneous platelet subpopulations with a range of primed or refractory phenotypes gradually arise in chronic inflammatory and other conditions in a manner that may indicate or support disease. Qualitatively distinguishable platelet phenotypes are increasingly associated with a variety of physiological and pathological circumstances; however, the origins and significance of platelet phenotypic variation remain unclear and conceptually vague. As changes in platelet function in disease exhibit many similarities to platelets following the activation of platelet agonist receptors, the intracellular responses of platelets common to hemostasis and inflammation may provide insights to the molecular basis of platelet phenotype. Here, we review concepts around how protein-level relations-from platelet receptors through intracellular signaling events-may help to define platelet phenotypes in inflammation, immune responses, aging, and other conditions. We further discuss how representing systems-wide platelet proteomics data profiles as circuit-like networks of causally related intracellular events, or, pathway maps, may inform molecular definitions of platelet phenotype. In addition to offering insights into platelets as druggable targets, maps of causally arranged intracellular relations underlying platelet function can also advance precision and interceptive medicine efforts by leveraging platelets as accessible, dynamic, endogenous, circulating biomarkers of vascular wellness and disease. Graphic Abstract: A graphic abstract is available for this article.

Citing Articles

Demographic diversity in platelet function and response to antiplatelet therapy.

Jain K, Tyagi T, Gu S, Faustino E, Hwa J Trends Pharmacol Sci. 2024; 46(1):78-93.

PMID: 39672782 PMC: 11710996. DOI: 10.1016/j.tips.2024.11.005.


Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms.

Kelliher S, Gamba S, Weiss L, Shen Z, Marchetti M, Schieppati F Blood Adv. 2024; 8(16):4276-4280.

PMID: 38861353 PMC: 11372589. DOI: 10.1182/bloodadvances.2023012016.


Aging-related alterations in mechanistic target of rapamycin signaling promote platelet hyperreactivity and thrombosis.

Portier I, Manne B, Kosaka Y, Tolley N, Denorme F, Babur O J Thromb Haemost. 2024; 22(9):2576-2588.

PMID: 38849085 PMC: 11656450. DOI: 10.1016/j.jtha.2024.05.025.


Platelet proteomics emerges from the womb: mass spectrometry insights into neonatal platelet biology.

Babur O, Emili A, Aslan J J Thromb Haemost. 2024; 22(5):1313-1315.

PMID: 38670684 PMC: 11528690. DOI: 10.1016/j.jtha.2024.01.020.


Heterogeneity of platelets and their responses.

Thomas S, Kelliher S, Krishnan A Res Pract Thromb Haemost. 2024; 8(2):102356.

PMID: 38666061 PMC: 11043642. DOI: 10.1016/j.rpth.2024.102356.


References
1.
Holly S, Chang J, Li W, Niessen S, Phillips R, Piatt R . Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation. Chem Biol. 2013; 20(9):1125-34. PMC: 3948353. DOI: 10.1016/j.chembiol.2013.07.011. View

2.
Zhou Z, Gushiken F, Bolgiano D, Salsbery B, Aghakasiri N, Jing N . Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity. Circulation. 2012; 127(4):476-485. PMC: 4472638. DOI: 10.1161/CIRCULATIONAHA.112.132126. View

3.
Chiva-Blanch G, Padro T, Alonso R, Crespo J, de Isla L, Mata P . Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2019; 39(5):945-955. DOI: 10.1161/ATVBAHA.118.312414. View

4.
Beck F, Geiger J, Gambaryan S, Solari F, DellAica M, Loroch S . Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017; 129(2):e1-e12. PMC: 5248936. DOI: 10.1182/blood-2016-05-714048. View

5.
Barrachina M, Sueiro A, Izquierdo I, Hermida-Nogueira L, Guitian E, Casanueva F . GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity. Atherosclerosis. 2019; 281:62-70. PMC: 6403451. DOI: 10.1016/j.atherosclerosis.2018.12.023. View